← Back to Search

Stem Cell Therapy

Intravitreal autologous CD34+ cells for Retinitis Pigmentosa (BMSCRP1 Trial)

Phase 1
Waitlist Available
Led By Susanna Park, MD PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group

Summary

This trial will test whether it is safe to give participants with retinitis pigmentosa an injection of their own stem cells in order to improve their vision.

Eligible Conditions
  • Retinitis Pigmentosa

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of intravitreal injection of autologous CD34+ cells
Safety of intravitreal injection of autologous CD34+ cells
Secondary study objectives
Best corrected visual acuity
Electroretinography
Microperimetry
+2 more

Awards & Highlights

All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intravitreal autologous CD34+ cellsExperimental Treatment1 Intervention
Intravitreal injection of autologous CD34+ cells harvested from bone marrow under GMP conditions

Find a Location

Who is running the clinical trial?

The Retina SocietyUNKNOWN
University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,755,677 Total Patients Enrolled
2 Trials studying Retinitis Pigmentosa
453 Patients Enrolled for Retinitis Pigmentosa
Cures Within ReachOTHER
23 Previous Clinical Trials
2,155 Total Patients Enrolled
1 Trials studying Retinitis Pigmentosa
8 Patients Enrolled for Retinitis Pigmentosa
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top